FDMT
Price
$14.47
Change
-$0.24 (-1.63%)
Updated
Sep 25 closing price
Capitalization
799.38M
46 days until earnings call
Intraday BUY SELL Signals
MENS
Price
$2.03
Change
-$0.12 (-5.58%)
Updated
Sep 25 closing price
Capitalization
150.69M
Intraday BUY SELL Signals
Interact to see
Advertisement

FDMT vs MENS

FDMT vs MENS Comparison Chart in %
View a ticker or compare two or three
VS
FDMT vs. MENS commentary
Sep 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and MENS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
FDMTMENS
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 27, 2026
Stock price -- (FDMT: $14.47 vs. MENS: $2.03)
Brand notoriety: FDMT and MENS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 97% vs. MENS: 45%
Market capitalization -- FDMT: $799.38M vs. MENS: $150.69M
FDMT [@Biotechnology] is valued at $799.38M. MENS’s [@Biotechnology] market capitalization is $150.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 1 FA rating(s) are green while MENS’s FA Score has 1 green FA rating(s).

  • FDMT’s FA Score: 1 green, 4 red.
  • MENS’s FA Score: 1 green, 4 red.
According to our system of comparison, FDMT is a better buy in the long-term than MENS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 4 TA indicator(s) are bullish while MENS’s TA Score has 5 bullish TA indicator(s).

  • FDMT’s TA Score: 4 bullish, 4 bearish.
  • MENS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both FDMT and MENS are a good buy in the short-term.

Price Growth

FDMT (@Biotechnology) experienced а -4.93% price change this week, while MENS (@Biotechnology) price change was -1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

FDMT is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
FDMT
Daily Signal:
Gain/Loss:
MENS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTW2.100.07
+3.45%
CTW
QDEL10.940.25
+2.34%
QuidelOrtho Corp
PRSO0.51N/A
+0.75%
Peraso
MHO138.750.99
+0.72%
M/I Homes
OTIS65.94-0.74
-1.11%
Otis Worldwide Corp

MENS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MENS has been loosely correlated with VTGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MENS jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MENS
1D Price
Change %
MENS100%
-5.58%
VTGN - MENS
58%
Loosely correlated
-7.46%
KYTX - MENS
37%
Loosely correlated
-2.58%
BNTC - MENS
28%
Poorly correlated
-0.52%
FDMT - MENS
27%
Poorly correlated
-1.63%
TRAW - MENS
27%
Poorly correlated
+0.57%
More